Pathmanathan Rajadurai
Overview
Explore the profile of Pathmanathan Rajadurai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rajadurai P, Yap N, Chiew S, Md Zin R, Md Pauzi S, Jaafar A, et al.
J Breast Cancer
. 2024 Dec;
27(6):362-371.
PMID: 39622509
Purpose: Triple-negative breast cancer (TNBC) is a subtype of breast cancer known for its poor prognosis and the absence of viable targets for standard receptor-based therapies. Several studies have suggested...
2.
Yap N, Perumal K, Rajadurai P
Ecancermedicalscience
. 2024 Oct;
18:1734.
PMID: 39421181
Human epidermal growth factor receptor 2 (HER2) is known for its oncogenic activities in diverse cancers, including non-small cell lung cancer (NSCLC). However, the prevalence of alterations in Malaysian NSCLC...
3.
Pan J, Tan Z, Ng P, Ahmad Zabidi M, Nur Fatin P, Teo J, et al.
NPJ Breast Cancer
. 2024 Jul;
10(1):60.
PMID: 39030225
Triple-negative breast cancers (TNBCs) are a subset of breast cancers that have remained difficult to treat. A proportion of TNBCs arising in non-carriers of BRCA pathogenic variants have genomic features...
4.
Rajadurai P, Ravindran S, Lee B, Md Pauzi S, Chiew S, Teoh K, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001387
Breast cancer is one of the most common cancers in Malaysia. Recently, a new nomenclature was introduced for breast cancers with human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC)...
5.
Pan J, Ragu M, Chan W, Hasan S, Islam T, Teoh L, et al.
Breast Cancer Res
. 2024 Apr;
26(1):67.
PMID: 38649964
Breast cancer exhibits significant heterogeneity, manifesting in various subtypes that are critical in guiding treatment decisions. This study aimed to investigate the existence of distinct subtypes of breast cancer within...
6.
Chai A, Yee S, Lee H, Aziz N, Yee P, Marzuki M, et al.
Cancer Res Commun
. 2024 Feb;
4(3):645-659.
PMID: 38358347
Significance: NPC268 is the first and only EBV-positive cell line derived from a primary non-keratinizing, differentiated nasopharyngeal carcinoma, an understudied but important subtype in Southeast Asian countries. This model adds...
7.
Ragu M, Lim J, Ng P, Yip C, Rajadurai P, Teo S, et al.
Breast Cancer Res
. 2023 Apr;
25(1):48.
PMID: 37101199
Background: Recent genomics studies of breast cancer in Asian cohorts have found a higher prevalence of TP53 mutations in Asian breast cancer patients relative to Caucasian patients. However, the effect...
8.
Kuan J, Chai S, Rajadurai P, Lau L, Uchang J, Syed Husain S
Case Rep Hematol
. 2022 Sep;
2022:4081971.
PMID: 36092151
Central nervous system (CNS) involvement in multiple myeloma (MM) (MM-CNS) in the form of leptomeningeal myelomatosis or brain parenchyma plasmacytoma is rare, causing challenges in clinical diagnosis and treatment. We...
9.
Wan K, Sen A, Selvaratnam L, Naing M, Khoo J, Rajadurai P
BMC Med Educ
. 2022 Jul;
22(1):587.
PMID: 35907832
Literature review demonstrated a surprising lack of publications on digital e-learning pathology resources for senior medical undergraduates and interns. An interactive Digital Pathology Repository (iDPR) integrating two- and three-dimensional (2D,...
10.
Woodhull S, Wang J, Kulasegarah J, Terumalay S, Rajadurai P, Tan Z, et al.
Clin Pediatr (Phila)
. 2022 Mar;
61(5-6):408-411.
PMID: 35238210
No abstract available.